Blue or green dye eye surgery to help remove retinal tissue
Part of Eyes & vision clinical trials.
This trial studies an eye surgery technique that uses a colored dye (blue or green) to help the surgeon carefully remove a thin inner retinal layer. It may help make the procedure more precise and safer, and the study compares how the dye-assisted method works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have not had any dye-assisted “chromovitrectomy” surgery in the last 6 months
- In your surgery, the plan is to use only one dye from the following: Brilliant Blue (BBG), Indocyanine Green (ICG), or (not both) Trypan Blue (TB)
- Do not be pregnant at the time of the surgery
- Have no other chromovitrectomy in the last 6 months (this includes any prior similar surgery)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a micropulsed laser can reduce swelling in the macula (central vision area) in people with inherited retinal diseases. It may help improve or stabilize vision-related swelling seen on detailed eye scans.
This study tests a new medicine, BI 1815368, to see if it can help people with diabetic macular edema, a condition that causes swelling in the back of the eye and can blur vision. If you qualify, you may be able to try this treatment and help researchers learn if it works.
This trial tests whether a specific eye surgery plus targeted clot-busting medicine and gas can improve vision after bleeding under the retina from “wet” age-related macular degeneration. It aims to reduce how long the bleeding lasts and help protect the central vision.
This study tests combining vitrectomy (surgery to remove the membrane from the retina) with a dexamethasone implant (a tiny steroid that is placed inside the eye to reduce swelling) for people with a specific type of eye membrane and fluid buildup in the center of the retina.
This study is for people who have a stage III or IV epiretinal membrane, a thin layer of scar tissue on the retina that can cause blurry or distorted central vision. It tests a surgical approach called controlled macular detachment to see how it helps visual symptoms and recovery.
This study tests a robotic system to assist eye surgery for certain retina and vitreous conditions, such as bleeding in the eye or a wrinkle on the macula. It aims to see if the robot can safely help improve vision.
Hear when a new Macular Edema trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.